KK
Krish S Krishnan
President and CEODirector10% Owner

Krish S Krishnan insider trades: Krystal Biotech (KRYS) stock buys and sales

President and CEO, Krystal Biotech Last trade Sep 4, 2026 53 Form 4 filings
$26.6M
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
57
Open-market trades
since 2005
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Krish reports to the SEC

Open-market buys and sales

57 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 4, 2026KRYS↓ Sell10b5-1$9.0M
Mar 4, 2026KRYS↓ Sell10b5-1$6.6M
Dec 4, 2025KRYS↓ Sell10b5-1$5.5M
Dec 4, 2025KRYS↓ Sell10b5-1$5.5M
Jul 16, 2025KRYS↓ Sell10b5-1$2.7M
Jul 16, 2025KRYS↓ Sell10b5-1$2.7M
Jul 10, 2025KRYS↓ Sell10b5-1$1.1M
Jul 10, 2025KRYS↓ Sell10b5-1$1.1M
Mar 13, 2025KRYS↓ Sell10b5-1$4.4M
Mar 13, 2025KRYS↓ Sell10b5-1$4.4M
Dec 13, 2024KRYS↓ Sell$4.1M
Dec 13, 2024KRYS↓ Sell$4.1M
Sep 12, 2024KRYS↓ Sell$4.9M
Sep 12, 2024KRYS↓ Sell$4.9M
Jun 11, 2024KRYS↓ Sell$4.4M
Jun 11, 2024KRYS↓ Sell$4.4M
Mar 11, 2024KRYS↓ Sell$4.3M
Mar 11, 2024KRYS↓ Sell$4.3M
Dec 11, 2023KRYS↓ Sell$2.6M
Dec 11, 2023KRYS↓ Sell$2.6M
Sep 11, 2023KRYS↓ Sell$3.2M
Sep 11, 2023KRYS↓ Sell$3.2M
May 31, 2023KRYS↓ Sell$2.9M
May 31, 2023KRYS↓ Sell$2.9M
Apr 17, 2023KRYS↓ Sell$2.2M
Apr 17, 2023KRYS↓ Sell$2.2M
Jan 18, 2023KRYS↓ Sell$2.0M
Jan 18, 2023KRYS↓ Sell$2.0M
Jan 4, 2023KRYS↓ Sell$315K
Jan 4, 2023KRYS↓ Sell$300K
Jan 3, 2023KRYS↓ Sell$780K
Jan 3, 2023KRYS↓ Sell$780K
Dec 16, 2022KRYS↓ Sell$847K
Dec 16, 2022KRYS↓ Sell$843K
Nov 23, 2022KRYS↓ Sell$320
Nov 8, 2022KRYS↓ Sell$77K
Nov 8, 2022KRYS↓ Sell$66K
Aug 5, 2022KRYS↓ Sell$2.0M
Aug 5, 2022KRYS↓ Sell$2.0M
Dec 10, 2021KRYS↓ Sell$7.0M
May 18, 2020KRYS↓ Sell$2.9M
Feb 20, 2020KRYS↓ Sell$3.1M
Nov 18, 2019KRYS↓ Sell$2.6M
Oct 18, 2018KRYS↑ Buy$500K
Mar 19, 2018KRYS↑ Buy$550K
Sep 22, 2017KRYS↑ Buy$1.0M
Dec 4, 2015XON↓ Sell$745K
May 9, 2014XON↑ Buy$297K
Nov 10, 2006NRPH↓ Sell$4.4M
May 18, 2006NRPH↓ Sell$876K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other KRYS insiders

Open-market trades in the last 12 months

About Krish S Krishnan's insider trades

Krish S Krishnan is President and CEO at Krystal Biotech (KRYS). Since Jun 15, 2005, Krish has reported 4 open-market purchases worth $2.3M and 53 sales worth $141.2M on SEC Form 4. In the last 12 months: 4 sales ($26.6M).

10 sales (30% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include option exercises (14 filings), grants and awards (9 filings), shares withheld for taxes (6 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KRYS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.